A rapid urinary test for combining PSA and zinc to enhance prostate cancer diagnosis: results from a prospective study
This uPSA/uZinc urine test is a promising adjunct to current diagnostic pathways, improving accuracy in detecting clinically significant PCa while reducing unnecessary biopsies. Its integration with mpMRI and SOC parameters could refine risk assessment and personalize patient management.
Authors
- Sergio Occhipinti (ORCID: https://orcid.org/0000-0002-1059-4901)
- Thea Serra
- Francesco Porpiglia (ORCID: https://orcid.org/0000-0001-8567-6795)
- Fabio Di Nardo (ORCID: https://orcid.org/0000-0003-0497-4251)
- Sabrina De Cillis (ORCID: https://orcid.org/0000-0002-7798-6926)
- Daniele Amparore (ORCID: https://orcid.org/0000-0001-5425-5453)
- Cristian Fiori (ORCID: https://orcid.org/0000-0002-6345-1322)
- Davide Zamengo (ORCID: https://orcid.org/0000-0001-9857-4130)
- Michele Ortenzi
- Eugenio Alladio (ORCID: https://orcid.org/0000-0001-9362-6907)
Institutions
- Candiolo Cancer Institute (IT)
- Ospedale San Luigi Gonzaga (IT)
- University of Turin (IT)
Publication Details
- Journal
- Prostate Cancer and Prostatic Diseases
- Published
- 2025-12-08
- DOI
- https://doi.org/10.1038/s41391-025-01030-2
- Citations
- 2
- Primary Topic
- Prostate Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 3.04